See more : ServisFirst Bancshares, Inc. (SFBS) Income Statement Analysis – Financial Results
Complete financial analysis of Xiamen Voke Mold & Plastic Engineering Co., Ltd. (301196.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Xiamen Voke Mold & Plastic Engineering Co., Ltd., a leading company in the Manufacturing – Metal Fabrication industry within the Industrials sector.
- Jianpu Technology Inc. (ADRs) (US47738D3098.SG) Income Statement Analysis – Financial Results
- Power & Digital Infrastructure Acquisition II Corp. (XPDBW) Income Statement Analysis – Financial Results
- Mare Nostrum Société anonyme (ALMAR.PA) Income Statement Analysis – Financial Results
- Irving Resources Inc. (IRVRF) Income Statement Analysis – Financial Results
- EQ Energy Drink, Inc. (EQLB) Income Statement Analysis – Financial Results
Xiamen Voke Mold & Plastic Engineering Co., Ltd. (301196.SZ)
About Xiamen Voke Mold & Plastic Engineering Co., Ltd.
Xiamen Voke Mold & Plastic Engineering Co., Ltd. engages in the research, development, design, manufacture, and sale of various injection molds in China and internationally. The company offers car center console, car air outlet housing, grille, engine connection body, air outlet high-gloss panel, car button two-color mold, six fuel tank two-color housing, car panel housing, steering wheel airbag, car dashboard housing, car instrument internal structure shell, car glove box shell, and auto electric tailgate spring sleeve products used in automotive field. It also provides electronic cigarette case, pen cap, micro injection - hearing aid, optical cable communication shell, electronic connector, and 5G communication base station cooling fan products for use in electronic field; multi-cavity cosmetic mold, baby carriage decorative cover shell, and baby wheel hub housing products used in home filed; and analysis box shell, medical laryngeal mask, medical oxygen mask, medical breathing ball, bed drive, and silicone oxygen mask for other markets. The company was founded in 1995 and is headquartered in Xiamen City, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.34B | 958.10M | 1.16B | 910.54M | 699.26M | 641.33M | 531.35M |
| Cost of Revenue | 917.09M | 641.85M | 766.58M | 583.32M | 439.31M | 399.97M | 296.90M |
| Gross Profit | 423.98M | 316.25M | 392.56M | 327.21M | 259.95M | 241.36M | 234.45M |
| Gross Profit Ratio | 31.62% | 33.01% | 33.87% | 35.94% | 37.17% | 37.63% | 44.12% |
| Research & Development | 69.25M | 58.04M | 43.85M | 32.61M | 33.82M | 25.90M | 20.25M |
| General & Administrative | 72.51M | 24.52M | 25.26M | -226.77M | -271.19M | -218.49M | 71.94M |
| Selling & Marketing | 19.83M | 29.28M | 26.12M | 22.00M | 29.53M | 25.75M | 22.23M |
| SG&A | 92.34M | 53.79M | 51.38M | -204.77M | -241.66M | -192.74M | 94.17M |
| Other Expenses | 56.68M | 229.31K | -243.57K | 34.32M | 3.91M | 14.27M | -521.23K |
| Operating Expenses | 218.26M | 171.25M | 157.93M | 114.55M | 131.22M | 165.36M | 155.40M |
| Cost & Expenses | 1.14B | 813.11M | 924.51M | 697.87M | 570.54M | 565.34M | 452.30M |
| Interest Income | 4.80M | 9.34M | 152.99K | 958.48K | 505.38K | 468.48K | 72.00K |
| Interest Expense | 2.73M | 1.38M | 380.68K | 1.58M | 9.79M | 16.66M | 2.69M |
| Depreciation & Amortization | 97.44M | 67.49M | 60.93M | 51.44M | 45.65M | 38.43M | 23.38M |
| EBITDA | 294.59M | 239.27M | 281.23M | 239.94M | 156.15M | 93.04M | 97.22M |
| EBITDA Ratio | 21.97% | 27.32% | 25.58% | 30.20% | 31.67% | 26.09% | 19.35% |
| Operating Income | 205.72M | 180.31M | 225.59M | 192.75M | 112.07M | 53.83M | 71.67M |
| Operating Income Ratio | 15.34% | 18.82% | 19.46% | 21.17% | 16.03% | 8.39% | 13.49% |
| Total Other Income/Expenses | 881.89K | -10.30M | -9.99M | -7.22M | -3.60M | -2.37M | -521.24K |
| Income Before Tax | 206.60M | 180.54M | 225.35M | 193.23M | 111.22M | 53.22M | 71.15M |
| Income Before Tax Ratio | 15.41% | 18.84% | 19.44% | 21.22% | 15.90% | 8.30% | 13.39% |
| Income Tax Expense | 30.70M | 15.67M | 29.21M | 26.44M | 16.61M | 17.01M | 19.04M |
| Net Income | 168.07M | 163.45M | 191.80M | 160.76M | 95.23M | 34.78M | 51.86M |
| Net Income Ratio | 12.53% | 17.06% | 16.55% | 17.66% | 13.62% | 5.42% | 9.76% |
| EPS | 1.35 | 1.31 | 1.54 | 1.29 | 0.76 | 0.43 | 0.91 |
| EPS Diluted | 1.35 | 1.31 | 1.54 | 1.29 | 0.76 | 0.43 | 0.91 |
| Weighted Avg Shares Out | 124.80M | 124.80M | 124.80M | 124.80M | 124.80M | 80.32M | 57.04M |
| Weighted Avg Shares Out (Dil) | 124.80M | 124.80M | 124.80M | 124.80M | 124.80M | 80.32M | 57.04M |
Source: https://incomestatements.info
Category: Stock Reports